Intravesical therapy has been used in the management of superficial transitional cell carcinoma (TCC) of the urinary bladder (i.e., Ta, Tl, and carcinoma in situ) with specific objectives which include treating existing/residual tumor, preventing recurrence of tumor, preventing disease progression,
โฆ LIBER โฆ
The immunotherapy of prostate and bladder cancer
โ Scribed by Thomas H. Totterman; Angelica Loskog; Magnus Essand
- Book ID
- 109052037
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 152 KB
- Volume
- 96
- Category
- Article
- ISSN
- 1464-4096
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Immunotherapy of bladder cancer
โ
Unyime O. Nseyo; Donald L. Lamm
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 48 KB
๐ 2 views
The immunotherapy of prostate cancer
โ
Dalgleish, A G; Perry, M J A; Eaton, J D; Hrouda, D; Todryk, S M; Kirby, R S
๐
Article
๐
2000
๐
Nature Publishing Group
๐
English
โ 96 KB
Immunotherapy of prostate cancer
โ
Stephen J. Freedland; Allan J. Pantuck; Jeffrey Weider; Amnon Zisman; Arie S. Be
๐
Article
๐
2001
๐
Springer
๐
English
โ 267 KB
The role of adjunctive immunotherapy in
โ
Kimio Fujita
๐
Article
๐
1987
๐
John Wiley and Sons
๐
English
โ 304 KB
๐ 2 views
Keyhole limpet hemocyanin immunotherapy
โ
Lamm, Donald L. ;DeHaven, Jean I. ;Riggs, Dale R. ;Delgra, Catalina ;Burrell, Ro
๐
Article
๐
1993
๐
Springer
๐
English
โ 490 KB
Immunotherapy with dendritic cells for p
โ
Anna-Katharina Thomas-Kaskel; Cornelius F. Waller; Wolfgang Schultze-Seemann; He
๐
Article
๐
2007
๐
John Wiley and Sons
๐
French
โ 152 KB
## Abstract Radical prostatectomy for prostate cancer is followed by PSA recurrence in up to 40% of patients. One third of patients with biochemical relapse progress to uncurable metastatic disease. Therefore, alternative treatment modalities are needed both in the situation of PSA recurrence and i